These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

433 related articles for article (PubMed ID: 28253990)

  • 41. Mitochondria in aging and Alzheimer's disease.
    Crouch PJ; Cimdins K; Duce JA; Bush AI; Trounce IA
    Rejuvenation Res; 2007 Sep; 10(3):349-57. PubMed ID: 17708691
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Mitochondria-Targeted Molecules as Potential Drugs to Treat Patients With Alzheimer's Disease.
    Reddy AP; Reddy PH
    Prog Mol Biol Transl Sci; 2017; 146():173-201. PubMed ID: 28253985
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Amyloid precursor protein and mitochondrial dysfunction in Alzheimer's disease.
    Anandatheerthavarada HK; Devi L
    Neuroscientist; 2007 Dec; 13(6):626-38. PubMed ID: 17911214
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Role of mitochondrial dysfunction in Alzheimer's disease.
    Castellani R; Hirai K; Aliev G; Drew KL; Nunomura A; Takeda A; Cash AD; Obrenovich ME; Perry G; Smith MA
    J Neurosci Res; 2002 Nov; 70(3):357-60. PubMed ID: 12391597
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Alzheimer's disease and type 2 diabetes-related alterations in brain mitochondria, autophagy and synaptic markers.
    Carvalho C; Santos MS; Oliveira CR; Moreira PI
    Biochim Biophys Acta; 2015 Aug; 1852(8):1665-75. PubMed ID: 25960150
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The role of mitochondrial dysfunction in Alzheimer's disease pathogenesis.
    Ashleigh T; Swerdlow RH; Beal MF
    Alzheimers Dement; 2023 Jan; 19(1):333-342. PubMed ID: 35522844
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Molecular pathophysiology of impaired glucose metabolism, mitochondrial dysfunction, and oxidative DNA damage in Alzheimer's disease brain.
    Abolhassani N; Leon J; Sheng Z; Oka S; Hamasaki H; Iwaki T; Nakabeppu Y
    Mech Ageing Dev; 2017 Jan; 161(Pt A):95-104. PubMed ID: 27233446
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Alzheimer's disease: effects of β-amyloid on mitochondria.
    Tillement L; Lecanu L; Papadopoulos V
    Mitochondrion; 2011 Jan; 11(1):13-21. PubMed ID: 20817045
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Insights into mitochondrial dysfunction: aging, amyloid-β, and tau-A deleterious trio.
    Schmitt K; Grimm A; Kazmierczak A; Strosznajder JB; Götz J; Eckert A
    Antioxid Redox Signal; 2012 Jun; 16(12):1456-66. PubMed ID: 22117646
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Advanced Mitochondrial Respiration Assay for Evaluation of Mitochondrial Dysfunction in Alzheimer's Disease.
    Grimm A; Schmitt K; Eckert A
    Methods Mol Biol; 2016; 1303():171-83. PubMed ID: 26235066
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Regulation and roles of mitophagy at synapses.
    Palikaras K; Tavernarakis N
    Mech Ageing Dev; 2020 Apr; 187():111216. PubMed ID: 32084458
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The Triangle of Death in Alzheimer's Disease Brain: The Aberrant Cross-Talk Among Energy Metabolism, Mammalian Target of Rapamycin Signaling, and Protein Homeostasis Revealed by Redox Proteomics.
    Di Domenico F; Barone E; Perluigi M; Butterfield DA
    Antioxid Redox Signal; 2017 Mar; 26(8):364-387. PubMed ID: 27626216
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Mitochondrial dysfunction in aging and Alzheimer's disease: strategies to protect neurons.
    Reddy PH
    Antioxid Redox Signal; 2007 Oct; 9(10):1647-58. PubMed ID: 17696767
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Mitochondrial Ca
    Naia L; Ferreira IL; Ferreiro E; Rego AC
    Biochem Biophys Res Commun; 2017 Feb; 483(4):1069-1077. PubMed ID: 27485547
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The Therapeutic Potential of Mitochondria Transplantation Therapy in Neurodegenerative and Neurovascular Disorders.
    Khan MM; Paez HG; Pitzer CR; Alway SE
    Curr Neuropharmacol; 2023; 21(5):1100-1116. PubMed ID: 36089791
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Mitochondria, Cybrids, Aging, and Alzheimer's Disease.
    Swerdlow RH; Koppel S; Weidling I; Hayley C; Ji Y; Wilkins HM
    Prog Mol Biol Transl Sci; 2017; 146():259-302. PubMed ID: 28253988
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Mitochondrial therapeutic interventions in Alzheimer's disease.
    Van Giau V; An SSA; Hulme JP
    J Neurol Sci; 2018 Dec; 395():62-70. PubMed ID: 30292965
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Mitochondrial Function, Dynamics, and Permeability Transition: A Complex Love Triangle as A Possible Target for the Treatment of Brain Aging and Alzheimer's Disease.
    Stockburger C; Eckert S; Eckert GP; Friedland K; Müller WE
    J Alzheimers Dis; 2018; 64(s1):S455-S467. PubMed ID: 29504539
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Abnormal mitochondrial dynamics in the pathogenesis of Alzheimer's disease.
    Zhu X; Perry G; Smith MA; Wang X
    J Alzheimers Dis; 2013; 33 Suppl 1(0 1):S253-62. PubMed ID: 22531428
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Role of mitochondrial homeostasis and dynamics in Alzheimer's disease.
    Selfridge JE; E L; Lu J; Swerdlow RH
    Neurobiol Dis; 2013 Mar; 51():3-12. PubMed ID: 22266017
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 22.